University of Ottawa Breaking News Studies Assess Tumor Aneuploidy to Guide Immunotherapy Treatment Exscientia Receives UK Permission to Start AI-Aided Phase I/II Trial NICE Recommends BMS's Opdivo Plus Chemo for HER2-Negative, PD-L1-Positive Gastric Cancer SeekIn Receives CE-IVD Mark for Cancer Recurrence Monitoring Test OncoDNA, Eli Lilly Partner on Thyroid Cancer Biomarker Testing Halo Diagnostics, Ikonopedia Partner to Provide Genetic Testing for Breast Cancer
